News Snapshot:
Shares in Chinese pharma firm tank as Covid medicine questioned After reports questioned the efficacy of pills certified by the government as a coronavirus cure, shares of one of China’s top traditional medicine makers plummeted on Monday. As the cities confront their biggest Covid-19 outbreaks since the pandemic began, Shanghai officials have joined their Hong Kong counterparts in dispensing ‘Lianhua Qingwen,’ an herbal medication promoted for fever and sore throats. But on Sunday, popular Chinese health platform Dingxiang Yisheng said the capsules, made by Shijiazhuang Yiling Pharmaceutical, could not prevent cases of the virus, in a report then picked up...
